Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation

BACKGROUND: As a tissue-specific proangiogenic or antiangiogenic agent, angiopoietin-like 4 (ANGPTL4) has recently gained attention in many diseases, such as metabolic syndrome, cardiovascular disease and cancer. However, the roles of ANGPTL4 in angiogenesis and tumor growth in epithelial ovarian ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuxian, Gao, Jinghai, Liu, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968256/
https://www.ncbi.nlm.nih.gov/pubmed/33726754
http://dx.doi.org/10.1186/s12935-021-01865-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968256/
https://www.ncbi.nlm.nih.gov/pubmed/33726754
http://dx.doi.org/10.1186/s12935-021-01865-4

Ejemplares similares